Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0750
0.00 (0.00%)
Oct 8, 2026, 3:33 PM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 15.86 million as of October 9, 2026. It is the 41,067th most valuable company in the world and the 1,422nd biggest in Canada. Its market cap has decreased by 24.94% in one year.
Market Cap
15.86M
Enterprise Value
19.23M
Revenue
n/a
Global Rank
Country Rank
#1,422 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 15.86M, a decrease of -67.56%. That is a compound annual growth rate of -9.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 15.86M | -9.76% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 28.80M |
| Pharmala Biotech Holdings | 23.03M |
| Devonian Health Group | 22.25M |
| Onco-Innovations | 22.15M |
| Alzai Health | 20.09M |
| Lobe Sciences | 16.98M |
| Rapid Dose Therapeutics | 13.78M |
| Britannia Life Sciences | 10.70M |